We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Tern Plc | LSE:TERN | London | Ordinary Share | GB00BFPMV798 | ORD 0.02P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.07 | 2.04% | 3.50 | 3.30 | 3.70 | 3.75 | 3.50 | 3.55 | 4,031,639 | 15:03:56 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Finance Services | 66k | -10.45M | -0.0269 | -1.30 | 13.6M |
From May 2022 to May 2024
TIDMTERN
RNS Number : 3953W
Tern PLC
18 August 2022
18 August 2022
Tern Plc
("Tern" or the "Company")
Further re. FundamentalVR Fund Raise
In the Company's announcement dated 11 August 2022, the Company stated that FVRVS Limited ("FundamentalVR") had closed a second tranche of its Series B fund raising round, securing an additional GBP5 million in new investment (the "FundamentalVR Series B second tranche") from a new institutional investor at the same valuation as the first tranche, making a total of GBP13.2 million raised in Series B funding at this time.
The Company notes that in its press release dated 11 August 2022, FundamentalVR, an independent privately held company, stated that it "has raised an additional $20 million to significantly accelerate medical skill-transfer and increase surgical proficiency through its world-leading medical simulation platform, Fundamental Surgery."
Tern can confirm that all the information disclosed in its announcement dated 11 August 2022 is correct and understands that the figure of $20 million referred to by FundamentalVR includes committed contingent funding yet to be received by FundamentalVR. Such funding would be at the same valuation as the FundamentalVR Series B second tranche and would not affect the book value of Tern's investment in FundamentalVR.
Enquiries
Tern Plc via IFC Advisory Al Sisto (CEO) Sarah Payne (CFO) Allenby Capital Limited Tel: 0203 328 5656 (Nominated Adviser and Broker) David Worlidge / Alex Brearley (Corporate Finance) Matt Butlin / Kelly Gardiner (Sales and Corporate Broking) IFC Advisory Tel: 0203 934 6630 (Financial PR and IR) tern@investor-focus.co.uk Tim Metcalfe Graham Herring Florence Chandler
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
FURFLFVATLIDLIF
(END) Dow Jones Newswires
August 18, 2022 02:00 ET (06:00 GMT)
1 Year Tern Chart |
1 Month Tern Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
